NLRP3 and metabolic dysfunction-associated steatohepatitis: In NASH mouse models, epalrestat mitigated hepatic inflammation and improved pathological conditions by suppressing NLRP3 inflammasome activation.64 In addition to its hepatic benefits, epalrestat has protective effects on other systems.